Buy & Sell Oracle Corporation (ORCL) – Oracle Corporation Price Today
Aura AI Summary
Key Stats
- $552.43BMarket Cap
- TechnologySector
- -15.48%3M Drawdown
- $671.37BEnterprise Value
- 1.04%Dividend Yield
- 70 daysTypical Hold Time
Oracle Corporation (ORCL) is currently valued at a market capitalization of $552.43B, with an enterprise value of $671.37B. Over the past 52 weeks, Oracle Corporation has traded between a low of $136.39 and a high of $328.33, highlighting its annual price range. Over the past three months, Oracle Corporation has recorded a drawdown of -15.48%, reflecting recent price volatility. Oracle Corporation offers a dividend yield of 1.04%, with the most recent dividend of $0.50 paid on 09 Apr 26. On average, investors hold Oracle Corporation for approximately 70 days, indicating typical investor behavior on the platform.
About Oracle Corporation
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Most Recent News
Upcoming IPOs from Nvidia's major customers may challenge its investor dominance.
Nvidia has been a top AI investment as demand for AI chips surged, but the next wave of IPOs from major AI customers like SpaceX, OpenAI, and Anthropic could shift investor focus. These companies, while not competitors in hardware, may compete for in...

Salazar Resources identifies new copper-gold porphyry target in Ecuador amid rising copper prices.
Salazar Resources announced a new copper-gold porphyry system discovery at its 100%-owned Monja Project in southern Ecuador, featuring high-grade surface samples. This discovery comes as global copper prices hit record highs due to supply deficits, i...

Bempedoic acid shows promise in lowering LDL-C in children and statin-intolerant adults, per Esperion data.
Esperion Therapeutics presented new data at the 2026 European Atherosclerosis Society Congress showing bempedoic acid effectively lowers LDL cholesterol in children aged 6-17 with familial hypercholesterolemia and is well tolerated. A secondary analy...
